baber/WOPTO huggingface dataset:
Patent NZ-330780-A (NZ)
Title: Gas inlet system
Inventor: MEIER AUGENSTEIN WOLFRAM
IPC: G01N30/62
Filed: 1996-12-23
Abstract: A method and apparatus for introducing a reference gas into isotope mass spectrometer systems. The reference gas is introduced into the system before a combustion interface and yields Gaussian shaped peaks of the same form as those produced for sample constituents. In one embodiment of the present invention the gas inlet comprises three pipes which intersect at an intersection point wherein a reference gas and a secondary flow of a carrier gas can enter the inlet via separate pipes and can exit via third pipe before the secondary flow enters the combustion interface.
Patent NZ-331557-A (NZ)
Title: Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
Inventor: REYNOLDS ERIC CHARLES
IPC: C12P21/08
Filed: 1997-04-01
Abstract: The application provides a composition for use in raising an immune response directed against Porphyromonas gingivalis.  The composition includes a suitable adjuvant and/or acceptable carrier and one substantially purified P. gingivalis immunogen. The immunogen is selected from the group consisting of Antigen 1, Antigen 2, Antigen 3, Antigen 4 and epitope containing fragments thereof, in which: Antigen 1 is an antigen of P. gingivalis and has an internal amino acid sequence: DLENKGEATLLVTFGSSYKAPRETYAKIEKTFAAAYPDQR; Antigen 2 is an antigen of P. gingivalis and has an internal amino acid sequence: DNPDENPLEGDITQTHTEKYVLAED; Antigen 3 is an antigen of P. gingivalis and has an internal amino acid sequence: DVLLLDVTPLSLGIETMGGVMTYLIDANTTIPKLK;  and Antigen 4 is an antigen of P. gingivalis and has an internal amino acid sequence: VYNASISAVGNTSAIDPVVQIIHHN.
Patent NZ-333709-A (NZ)
Title: Co-milled mixtures of a polyol and a reaction product used in polyol fatty acid polyester manufacture
Inventor: ALEXANDER STEVEN ROBERT
IPC: C07H13/06
Filed: 1997-07-16
Abstract: This process is for using a mixture of polyol and at least one additional reaction component for the manufacture of polyol fatty acid polyesters  and comprises co-milling the polyol and the additional reaction component.  The co-milling reduces the particulate size of the polyol and the additional reaction component while creating particles which include an admixture of polyol and the additional reaction component.  The co-milled mixture of polyol and additional reaction component can be used, for example, as a feed stream for the transesterification reaction of the polyol to produce a polyol fatty acid polyester.
Patent NZ-335601-A (NZ)
Title: Active-substance-containing moulded bodies based on biodegradable thermoplastically processable polymers
Inventor: MULLER HANNS PETER
IPC: A01N25/32
Filed: 1997-10-27
Abstract: Shaped articles which comprise active compounds and are based on thermoplastically processable, biologically degradable polymers, preferably polyesters, polyester amides, polyester urethanes and polyester urethane ureas.  Also disclosed is the use of the article as tapes, medallions and ear tags for combating parasites on and in the environment of animals. In addition, there is disclosed a use of the article following comminution, granulation or grinding as a soil granule for combating phytopathogenic insects on plants.
Patent NZ-500672-A (NZ)
Title: Paperboard inner pack for elongate smoking articles
Inventor: JAMES ANTHONY GEORGE
IPC: A24F15/00
Filed: 1998-05-01
Abstract: A pack (13) for elongate smoking articles encased in an inner wrapping and comprising a paperboard outer container having a generally rectangular base (14), four hingedly connected side walls (15-20) which upstand from the said base, and top panel means (22) which at least partially closes off the top of the pack.  The side walls (15-20) are substantially the same height as the smoking articles and are secured with respect to the base.  Access to the smoking articles is made by way of the top panel means (22).  Junctions between adjoining pairs of walls (21) are contoured, either as radiused or beveled junctions.
Patent NZ-504457-A (NZ)
Title: 2-aryl-8-oxodihydropurine derivatives for treating anxiety-related diseases
Inventor: MURATA TERUYA
IPC: A61P25/00
Filed: 1998-11-26
Abstract: 2-Aryl-8-oxodihydropurine derivative of the formula (I): wherein W is H, lower alkyl, halogen, lower alkoxy, amino, mono- or di-lower alkylamino, or substituted or unsubstituted phenyl; X is H, lower alkyl, cycloalkyl-lower alkyl, substituted or unsubstituted phenyl-lower alkyl, lower alkenyl, carbamoyl, di-lower alkylcarbamoyl, or the formula (Q): -CH(R3)CON(R1)(R2); Y is H, lower alkyl, cycloalkyl, cycloalkyl-lower alkyl, lower alkenyl, substituted or unsubstituted phenyl-lower alkyl, or the formula (Q): -CH(R3)CON(R1)(R2); A is substituted or unsubstituted phenyl, or substituted or unsubstituted heteroaryl; provided that when one of X and Y of the above formula (I) is the group of the formula (Q), then the other is the same groups for X or Y as described above except for the group of the formula (Q), or a pharmaceutically acceptable acid addition salt thereof. These compounds are useful for the prophylaxis or treatment of central nervous disorders such as anxiety-related diseases (neurosis, somatoform disorders, anxiety disorders, and others), depression, epilepsy, or circulatory organs disorders such as angina pectoris, hypertension.
Patent NZ-506681-A (NZ)
Title: Disinfecting composition
Inventor: BRANDSBORG ERIK
IPC: A61K31/19
Filed: 1999-03-16
Abstract: A disinfecting composition comprising: (a) 2,4-dichlorobenzyl alcohol, (b) glycerylmonolaurate, and (c) a vehicle, such as water or alcohol. Also described is a method for the treatment of human or animal skin comprising applying to the skin an effective amount the above disinfecting composition.
Patent NZ-508801-A (NZ)
Title: Selective estrogen receptor modulator in combination with dehydroepiandrosterone (DHEA) or analogues
Inventor: LABRIE FERNAND
IPC: A61K31/4453
Filed: 1999-06-10
Abstract: A combination composition comprising a selective estrogen receptor modulator and a sex steroid precursor selected from the group consisting of dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate, androst-5-ene-3 â,17â-diol and 4-androstene-3,17-dione.  Also disclosed is the use of such to treat cancers, and kits comprising such.
Patent NZ-513609-A (NZ)
Title: Thermal method for application of organic treatment fluids
Inventor: NEWSON RICHARD JOHN
IPC: A01K7/00
Filed: 2001-08-20
Abstract: A method for killing or controlling weeds, insects, fungi, the release of spores, bacteria or sterilizing a substrate, including exposing the weeds, fungi, insects or insect eggs, spores or substrate to heat by blowing hot air onto the weeds, fungi, insects or insect eggs, spores or substrate and immediately thereafter or before or simultaneously applying a liquid substance including a herbicide and or pesticide and/or fungicide, and/or bacteriacide, and/or fish or animal derived substance to the weeds, fungi, insects, spores or substrate.
Patent NZ-515099-A (NZ)
Title: A process for preparing alkyl cobalt (III) dioximates
Inventor: GRIDNEV ALEXEI A
IPC: C07C251/70
Filed: 2001-10-29
Abstract: An alkyl cobalt (III) dioximate of formula (I) and a process for making alkyl cobalt (III) dioximate of formula (I): where R1, and R2 are H, alkyl having at least 2 carbon atoms, substituted alkyl, aryl, substituted aryl, COOR5, C0NR6R7, SR7, SO2R7, SO2NR5R6, SOR5, SO3R5, halogen, CCl3, CF3, COR5, CHO, CR6R7OR5, CH(OR5)(OR6), CR5(OR6)(OR7); R5, R6, and R7 are H, optionally substituted alkyl or optionally substituted aryl; A is a substituted alkyl derived from an olefinic component such as and alkyl acrylate ester; and B is a component of a Lewis base such as an imidazole, a phosphine or a phosphite, and where the substituents of the substituted alkyl are an ester, ether, amide, halogen, ketone, hydroxy, aryl, SO2-alkyl, sulfamido, or amino groups and the substituents for the substituted aryl are an ester, ether, amide, halogen, ketone, hydroxy, alkyl, SO2-alkyl, sulfamido, or amino groups.
Patent NZ-517655-A (NZ)
Title: Seamless WLAN network
Inventor: WU GANG
IPC: H04W72/00
Filed: 2002-03-07
Abstract: A network system integrating radio systems for cellular networks with a basic network access component provided in a mobile host, that interacts with basic access network base stations over a basic access network channel via radio using basic access network protocol, which differs from the user communications protocol, to communicate with the core network.
Patent NZ-517940-A (NZ)
Title: Clip-on pipe support with a spacing flange
Inventor: SMITH STUART MATTHEW
IPC: F16L3/13
Filed: 2002-03-25
Abstract: The peg consists of a U shaped cradle, a stake for insertion into the ground and a circular flange. When in use the peg may be inserted into the ground to a depth defined by the circular flange and a pipe may be positioned in the U shaped cradle to hold it at a fixed height above the ground. The device is particularly used to comply with plumbing and drainage standards .
Patent NZ-518934-A (NZ)
Title: Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
Inventor: DRAGOVICH PETER S
IPC: C07D409/12
Filed: 2000-12-01
Abstract: Compounds of formula (I), wherein: Ra is optionally substituted heterocycloalkyl or heterocycloalkylalkyl, Rb has the formula (II), Rc is H, halogen or optionally substituted alkyl, Rd is H halogen, hydroxyl, optionally substituted alkyl, alkoxy or alkylthio, Re is H or optionally substituted alkyl, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of diseases mediated by picornaviral protease activity.
Patent NZ-524766-A (NZ)
Title: Infant drinking cup
Inventor: WEBB IAN ALEXANDER
IPC: A47G19/22
Filed: 2001-07-25
Abstract: An infant cup includes a cup body (12) having opposed handles (14), a cover (16), a flexible mouthpiece (24) and a valve element (26). The cup body (12) is of generally circular cross section allowing the infant to grip the cup firmly. The cover (16) has a threaded skirt (18) allowing the cover (16) to be screwed into a cooperating screw thread (20) in the cup body (12). The mouthpiece (24) receives a valve element (26). The mouthpiece (24) and valve element (26) are retained on the cover (16) by a retaining element (28) having a screw thread (30) allowing it to be screwed into place on a cooperating formation (not shown) on the underside of the cover (16) holding the mouthpiece (24) and valve element (26) firmly in place relative to the cover (16) and one another. The mouthpiece (24) is positively located and correctly positioned by virtue of the elliptical orifice (22) in the cover (16). The thread (18) on-the cover (16) and the cooperating thread (20) on the cup body (12) are configured to ensure that the mouthpiece is positioned optimally relative to the handles of the cup (14) for infant use when the cover (16) is screwed into position.
Patent NZ-530915-A (NZ)
Title: Antimicrobial oral rinse solid composition to be dispersed in water prior to use in the oral cavity
Inventor: SHERMAN BERNARD CHARLES
IPC: A61P31/10
Filed: 2004-02-02
Abstract: A solid antimicrobial composition comprising an antifungal and an antibacterial agent that effectively decreases antimicrobial activity in the mouth is described. The composition, which may be a powder, tablet or in a sachet or other unit-dose package, is used after dispersal in water whereby the oral cavity is rinsed after and the dispersion is expectorated.
Patent NZ-534264-A (NZ)
Title: Asymmetrical hammock
Inventor: HENNESSY THOMAS F
IPC: A45F3/22
Filed: 2003-01-06
Abstract: A hammock includes a bed made of a piece of flexible material gathered by folding at opposite ends. Ropes are attached to the gathered ends whereby the bed can be suspended from trees. The edges of the bed are drawn apart along a tension axis which is s diagonal to the suspension axis, giving the bed the shape of a non-equilateral polygon so that one can lie diagonally across the suspension axis, whereby the back is well supported.
Patent NZ-534340-A (NZ)
Title: Pharmaceutical dosage form for mucosal delivery
Inventor: MARTINO ALICE C
IPC: A61K9/34
Filed: 2003-02-06
Abstract: A pharmaceutically tablet comprises an excipient coating of gellan gum adherent to an intraorally disintegratable core. Also described are drugs the tablet can be selected from.
Patent NZ-536034-A (NZ)
Title: Container for storage processing of meat products
Inventor: PALMER ROGER KEITH
Filed: 2004-10-18
Abstract: An apparatus kit for the processing and storage of meat primals, includes a liddable container 54 having handling elements 55 on the external surface to allow automated handling of the container, and a plurality of processing devices for selective use with the container, each processing device being adapted for use with the container dependent on how the primals are to be stored or processed. The processing devices include a lid 56 for the container, a gassing element (valve) 58 for the container, a tray element to fit within the container, a press that fits within the container, and a cooler element that fits internal to the container.
Patent NZ-536962-A (NZ)
Title: Immunostimulatory oligonucleotides and uses thereof
Inventor: LOPEZ RICARDO AUGUSTIN
IPC: A61K39/35
Filed: 2003-05-30
Abstract: An immunostimulatory oligonucleotide, TCATCATTTTGTCATTTTGTCATT (SEQ ID NO:2) which is encapsulated in a slow release delivery system. The immunostimulatory oligonucleotide can be used in the manufacture of a medicament for inducing B-cell activation for preventing or treating or ameliorating an immune system disorder, a tumoral disease or for inducing plasmacytoid dendritic cell activation.
Patent NZ-537089-A (NZ)
Title: Interleukin 6 production inhibitor
Inventor: SHIRAKI KIMIYASU
IPC: A23L1/30
Filed: 2003-11-25
Abstract: The use of lactoperoxidase for the manufacture of a food or drink composition, a feed composition or a pharmaceutical preparation for preventing or treating a disease caused by the production of interleukin-6 wherein the disease is selected from the group consisting of thrombocytosis, myeloma, Castleman syndrome, cardiac myxoma, glomerulonephritis, rheumatoid arthritis, sepsis, and influenza-virus infectious disease.
Patent NZ-537861-A (NZ)
Title: Silica-rubber mixtures having improved hardness
Inventor: JOSHI PRASHANT G
IPC: C08K5/54
Filed: 2003-07-08
Abstract: Disclosed is a method for increasing the hardness of silica/rubber mixtures comprising blending with said mixture at least one silane and a hardness-increasing amount of at least one member selected from the group consisting of thixotropic- (hydrophilic and hydrophobic) fumed (pyrogenic) silica (commonly called thixotropic fumed silica) or precipitated silica wherein the total amount of silica is from 80 phr to 110 phr, wherein the silane is 3-octanoylthio-1-propyltriethoxysilane, and wherein said hardness increasing amount of silica is sufficient to achieve a Shore A hardness of from 56 to 63 and which is above the amount necessary to achieve equivalent Shore A hardness of the silica/rubber mixture as compared with the use of an equivalent molar amount of bis-(triethoxysilylpropyldisulfide) as the silane.
Patent NZ-538569-A (NZ)
Title: Therapeutic human anti-IL-1R1 monoclonal antibody
Inventor: VARNUM BRIAN
IPC: C07K16/28
Filed: 2003-09-05
Abstract: Disclosed is an isolated antibody that specifically binds interleukin-1 receptor type 1 (IL-1R1), comprising a heavy chain and a light chain, wherein the heavy chain comprises a heavy chain variable region comprising an amino acid sequence as set forth in any of SEQ ID NO: 10, SEQ ID NO: 14, or SEQ ID NO: 16, or an antigen-binding or an immunologically functional immunoglobulin fragment thereof. Also disclosed are uses of said antibody in the manufacture of medicaments.
Patent NZ-538595-A (NZ)
Title: Pyrazolopyridines as cyclin dependent kinase (CDK) inhibitors useful in treating diseases such as cancer, leukemia, fibrosarcoma and glioma
Inventor: DWYER MICHAEL P
IPC: C07D471/04
Filed: 2003-09-17
Abstract: A novel class of pyrazolo[1,5-a]pyridine compounds are described to be represented by the structural formula III. The substituents are defined herein. Also disclosed are methods of inhibiting cyclin dependent kinases (CDK), and treating diseases associated with cyclin dependant kinase such as cancer, leukaemia and lymphoma. The methods involve the administration of a therapeutically effective amount of at least one compound of formula III to a non-human animal.
Patent NZ-547872-A (NZ)
Title: Reagent for detecting an analyte
Inventor: NORRILD JENS CHRISTIAN
IPC: C07D401/12
Filed: 2004-12-14
Abstract: Disclosed is a reagent for use in detecting an analyte, comprising a fluorescent energy donor and an energy acceptor, the energy donor and the energy acceptor being such that when they are sufficiently close to one another energy is non-radiatively transferred from the energy donor following excitation thereof to the energy acceptor quenching fluorescence of the energy donor, wherein the energy acceptor is of the general formula (I), wherein the substituents are defined as in the specification. Also disclosed are dye compounds related to energy acceptor of formula (I), a method for detecting or measuring the analyte using the reagent and a complex of an analyte with the reagent.
Patent NZ-551614-A (NZ)
Title: Modular heated towel rail
Inventor: SHORT DAVID CHARLES WEIR
Filed: 2006-11-24
Abstract: A member for an electrical heating apparatus is disclosed. The member comprises coupling means for structurally and electrically coupling one or more elements to the member. The invention further provides a cooperating element and an apparatus including one or more of the members and/or one or more of the elements. An electrical heater is also provided, the heater having a plurality of points for connecting to an electrical power supply.
Patent NZ-552853-A (NZ)
Title: Lysine based compounds
Inventor: STRANIX BRENT RICHARD
Filed: 2004-08-02
Abstract: Disclosed is a lysine based compound of formula I or a pharmaceutically acceptable salt thereof, wherein the substituents are defined within the specification. Also disclosed is the use of a compound of formula I or a pharmaceutically acceptable salt thereof, in the manufacture of a drug for the treatment or prevention an HIV infection.
Patent NZ-555856-A (NZ)
Title: Cleaning in membrane filtration systems
Inventor: JOHNSON WARREN THOMAS
IPC: B01D65/02
Filed: 2005-12-19
Abstract: Disclosed is a method of cleaning permeable, hollow membranes in an arrangement of the type wherein a pressure differential is applied across the walls of the permeable, hollow membranes immersed in a liquid suspension, said liquid suspension being applied to the outer surface of the permeable, hollow membranes to induce and sustain filtration through the membrane walls wherein: (a) some of the liquid suspension passes through the walls of the membranes to be drawn off as clarified liquid or permeate from the hollow membrane lumens, and (b) at least some of the solids are retained on or in the hollow membranes or otherwise as suspended solids within the liquid surrounding the membranes, the method of cleaning comprising the steps of: i) removing, at least partially, liquid from the filtrate side of the membrane; ii) removing, at least partially, liquid from the outer side of the membrane; iii) applying a cleaning solution to the outer side of the membrane; iv) applying a pressure differential across said membrane wall to cause flow of said cleaning solution through said wall from the outer side of the membrane into the membrane lumen to at least partially fill said lumen with cleaning solution; v) isolating the outer side of the membrane; vi) applying a pressurized gas to the filtrate side of the membrane wall to cause flow of the cleaning solution back to the outer side through the membrane wall; vii) accumulating the increased pressure developed on the outer side of the membrane as a result of said flow of cleaning solution; viii) releasing the pressure applied by said pressurised gas to said filtrate side of the membrane wall to cause flow of said cleaning solution through said membrane from the outer side to the filtrate side under the effect of said accumulated pressure on the outer side of the membrane wall.
Patent NZ-556788-A (NZ)
Title: Humanized CRIPTO binding molecules with CDRs from murine B3F6
Inventor: GLASER SCOTT
IPC: A61K31/00
Filed: 2006-01-05
Abstract: Disclosed is a humanized form of murine B3F6, an anti-CRIPTO antibody.
Patent NZ-561684-A (NZ)
Title: An improved process for the purification of perindopril
Inventor: SINGH GIRIJ PAL
IPC: C07D209/42
Filed: 2005-06-09
Abstract: Disclosed is a process for the purification of perindopril, comprising: (i) treating perindopril with dicyclohexylamine in the presence of a solvent to form a salt of perindopril with dicyclohexylamine, (ii) isolating said dicyclohexylamine salt of a compound of formula (I), and (iii) treating the dicyclohexylamine salt of compound of formula (I) optionally in the presence of an organic solvent to form a salt with tert butyl amine, then, optionally, (iv) isolating compound of formula (I) with unknown impurities, and (v) converting to a dicyclohexylamine salt of compound of formula (I) with high purity. Also disclosed is another process for the purification of perindopril, comprising: (i) treating perindopril in a solvent with dicyclohexylamine to form a compound of formula (I) in the form of a salt with dicyclohexylamine, (ii) isolating said dicyclohexylamine salt of perindopril, (iii) treating perindopril in the form of a salt with dicyclohexylamine with an acidic agent to form perindopril free base, and (iv) isolating perindopril free base. Also disclosed is a dicyclohexylamine salt of perindopril.
Patent NZ-563134-A (NZ)
Title: Blow moulded containers where the mould is adapted to increase the crystallinity of the plastic at certain features
Inventor: KELLEY PAUL
IPC: B29C49/54
Filed: 2006-04-13
Abstract: A blow moulded container (500), a method for producing the container and a mould used in that method is disclosed. The container (500) has with a base having a moveable region (502) and a bearing surface (504). The method includes the steps of receiving a parison, enclosing the parison with a mould that includes a cavity, inflating the parison in the mould (300) to form a blow moulded container (500) with the moveable region (502) at the cavity and repositioning the moveable region (502) before filling the blow moulded container (500). Before the repositioning, at least a first portion of the moveable region (502) of the blow moulded container is arranged outwardly below the bearing surface (504), and at least a second portion of the moveable region (502) of the blow moulded container is arranged inwardly above the bearing surface (504). At this time the second portion of the moveable region (502) arranged inwardly, above the bearing surface (504) is located at the center of the moveable region of the blow moulded container. Also the first portion of the moveable region (502), arranged outwardly below the bearing surface (504), surrounds the second portion of the moveable region. This process increases the crystallinity of the plastic in the base, which enables the container to be 'hot filled' without uncontrolled physical distortion of the container as it cools.